Wells Fargo’s Medtronic MDT Stock Holding History

Wells Fargo’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-400,400	Closed	-$34.9M	–	7275
2025 Q2	$34.9M	Buy	400,400 +360,000	+891%	+$30.5M	0.01%	1050
2025 Q1	$3.63M	Buy	40,400 +40,000	+10,000%	+$3.58M	﹤0.01%	2668
2024 Q4	$32K	Hold	400	–	–	﹤0.01%	5624
2024 Q3	$36K	Hold	400	–	–	﹤0.01%	5462
2024 Q2	$31.5K	Sell	400 -439,000	-100%	-$36M	﹤0.01%	5449
2024 Q1	$38.3M	Buy	439,400 +439,000	+109,750%	+$37.5M	0.01%	878
2023 Q4	$33K	Hold	400	–	–	﹤0.01%	5436
2023 Q3	$31.3K	Hold	400	–	–	﹤0.01%	5413
2023 Q2	$35.2K	Hold	400	–	–	﹤0.01%	5566
2023 Q1	$32.2K	Buy	+400	New	+$32.6K	﹤0.01%	5405
2015 Q1	–	Sell	-91,000	Closed	-$16K	–	6273
2014 Q4	$16K	Sell	91,000 -239,000	-72%	-$16.6M	﹤0.01%	5455
2014 Q3	$547K	Buy	+330,000	New	+$21M	﹤0.01%	3846
2014 Q1	–	Sell	-385,200	Closed	-$31K	–	5983
2013 Q4	$31K	Buy	+385,200	New	+$21.8M	﹤0.01%	4876

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's MDT Position: Q1 2026 in Review

Wells Fargo increased its Medtronic (MDT) stake by 6.8% in Q1 2026, buying an estimated $45.5M and bringing the position to 7,514,778 shares worth $651M. The position accounts for 0.12% of the portfolio, ranked #161.

Wells Fargo first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.85B in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Wells Fargo held 7,514,778 shares of Medtronic worth $651M as of Q1 2026.
Wells Fargo bought 475,411 Medtronic shares in Q1 2026, an estimated $45.5M.
Medtronic made up 0.12% of Wells Fargo's portfolio in Q1 2026, its #161 holding.
Wells Fargo first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Medtronic position peaked at $1.85B in Q3 2021.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.